Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey

Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey

Introduction: Atrial fibrillation (AF) is the most common arrhythmia with a prevalence that increases by aging. AF causes morbidity and mortality due to thromboembolic events. In developing countries, the use of new generation medications can be delayed. Objective: We evaluated nonvalvular AF patien...

Full description

Bibliographic Details
Main Authors: Emre Ozdemir, Ozgen Safak, Sadik Volkan Emren, Mehmet Serdar Bayata
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:International Journal of the Cardiovascular Academy
Subjects:
atrial fibrillation
nonvalvular atrial fibrillation
novel oral anticoagulants
warfarin
Online Access:http://www.ijcva.com/article.asp?issn=2405-8181;year=2020;volume=6;issue=2;spage=66;epage=69;aulast=Ozdemir

Internet

http://www.ijcva.com/article.asp?issn=2405-8181;year=2020;volume=6;issue=2;spage=66;epage=69;aulast=Ozdemir

Similar Items